NCT00975988View on ClinicalTrials.gov

Regulatory TYKERB® Tablets PMS

CompletedOBSERVATIONAL

Enrollment

750

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Cancer

Interventions

DRUG

TYKERB® tablets

Patients administrated TYKERB® tablets according to the prescribing information

Trial Locations (2)

110-744

GSK Investigational Site, Seoul

134-701

GSK Investigational Site, Seoul

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY